Last reviewed · How we verify
SPARC147609
SPARC147609 is a drug under development by Sun Pharma Advanced Research Company Limited. It has completed a Phase 1 bioequivalence study in ovarian cancer patients, with no FDA label or approved indications yet. The drug's mechanism and safety profile are not fully detailed, and it is currently in the early stages of clinical development.
At a glance
| Generic name | SPARC147609 |
|---|---|
| Sponsor | Sun Pharma Advanced Research Company Limited |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SPARC147609 CI brief — competitive landscape report
- SPARC147609 updates RSS · CI watch RSS
- Sun Pharma Advanced Research Company Limited portfolio CI